Labiotech.eu

News and Trends 8 Sep 2021

As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues

Johnson & Johnson became the latest company to have a failed vaccine trial against HIV last week. While it was a great disappointment to many, efforts continue in this space, helped by recent Covid-19 vaccine advances. HIV has been around for decades. While antiretroviral treatments have improved enormously, turning what was once a death sentence […]

September 8, 2021 - 5 minutesmins - By Helen Albert

In Depth 6 Sep 2021

Why We Desperately Need to Develop New Antifungals

While serious fungal infections are rare, there is a limited number of approved drugs to treat them, and they may not always work due to the rise of antimicrobial resistance. Despite the challenges, researchers are starting to add new weapons to the arsenal to protect us against these microscopic invaders. Developing effective antifungals is a […]

September 6, 2021 - 10 minutesmins - By Helen Albert

News and Trends 2 Sep 2021

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II results this week, raising tentative hopes for the field of treatments targeting the protein tau. For decades, the major culprit responsible for Alzheimer’s disease was suggested to be the buildup of a protein called amyloid-beta in the brain. Blocking this […]

September 2, 2021 - 5 minutesmins - By Jonathan Smith

Best in Biotech 2 Sep 2021

The top 15 biotech companies to find in the Netherlands

The Netherlands has established itself as a biotech and life sciences hub, possessing leading academic and research institutions and an excellent business infrastructure that makes it an attractive place for biotech companies to grow and thrive. In this article, we take a look at some of the top biotechs in the country. The Netherlands is […]

September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

growth hormone deficiency ascendis pharma

News and Trends 1 Sep 2021

Slow-Release Jab for Child Growth Hormone Deficiency Gets FDA Nod

The FDA has given the green light to Danish company Ascendis Pharma for the first slow-release formulation that provides a weekly alternative to daily injections for children with growth hormone deficiency. For decades, patients with growth hormone deficiency have required tedious daily hormone injections to stave off the effects of the rare condition, including slow […]

September 1, 2021 - 5 minutesmins - By Jonathan Smith

Opinion 31 Aug 2021

Cloud Foundations for R&D: Designing the Future of Life Sciences

In recent years, artificial intelligence has been hailed as the next big thing in drug discovery. But to leverage the full potential of this technology the life sciences industry first needs to pay attention to experimental design and data collection. We embrace the latest digital technologies to enhance almost everything in our daily lives—from how […]

August 31, 2021 - 7 minutesmins - By External Contributor

lab-grown meat, stem cell technology, cultured meat, stem cells

Stem Cell-based Cultured Meat: No Longer Science Fiction

Since the turn of the century, stem cell technology has delivered on its promise to transform the healthcare industry, while its applications across different sectors have continued to emerge. Bioreactors, offering improved process control as well as scalability, have been adopted worldwide for stem cell production and cultivation. Join us as we dive into the […]

August 26, 2021 - 7 minutesmins - By Sudha Sundaram

In Depth 25 Aug 2021

After Years of Neglect, Algae Biotechnology Makes a Comeback

Despite their ability to create matter out of thin air, algae and cyanobacteria have long been neglected by the biotech industry. Recently, however, they have started to gain traction in new market niches. In the center of Paris, just across from Marie Curie’s old laboratory, Pierre Crozet, Associate Professor at Sorbonne University, studies photosynthesis. His […]

August 25, 2021 - 6 minutesmins - By Kostas Vavitsas

psychedelics psychiatric atai gh compass

News and Trends 24 Aug 2021

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

The UK has cemented its position as a European hub for psychedelics research following a €68.5M ($80M) Series B round from the startup Beckley Psytech. The Oxford-based Beckley Psytech — founded in 2019 to develop psychedelic treatments for neurological conditions — had originally set the target of its venture capital financing at €43M ($50M). Earlier […]

August 24, 2021 - 4 minutesmins - By Jonathan Smith

Interview 23 Aug 2021

Behind the Scenes at Novo Seeds: Building Startups from the Ground up

Søren Møller, Managing Investment Director at Novo Seeds, discusses how the firm’s investment strategy has changed over time to support the creation of biotech startups in the Nordics. Søren Møller has a PhD in molecular biology from the Technical University of Denmark. After spending some time as a postdoc at Stanford University in the US […]

August 23, 2021 - 9 minutesmins - By Helen Albert

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed phase III trials. The results of the phase III trial revealed that a single dose of the live attenuated vaccine developed by Valneva induced the […]

August 19, 2021 - 3 minutesmins - By Victor Kotsev

Expert Advice 18 Aug 2021

How to Pitch Your Biotech Startup to a Life Sciences Investor

You’ve got the idea. You’ve got the science. You’ve got the team. Now all you need is the money, but that can be a tricky step for a new biotech entrepreneur. In any field, getting in front of the right investors is a challenge of its own. Once you’re pitching, experienced investors and entrepreneurs say […]

August 18, 2021 - 9 minutesmins - By Mark Zipkin

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues

Why We Desperately Need to Develop New Antifungals

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

The top 15 biotech companies to find in the Netherlands

Slow-Release Jab for Child Growth Hormone Deficiency Gets FDA Nod

Cloud Foundations for R&D: Designing the Future of Life Sciences

Stem Cell-based Cultured Meat: No Longer Science Fiction

After Years of Neglect, Algae Biotechnology Makes a Comeback

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

Behind the Scenes at Novo Seeds: Building Startups from the Ground up

Chikungunya Vaccine First to Succeed in Phase III Trial

How to Pitch Your Biotech Startup to a Life Sciences Investor

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!